What is a significant risk for patients receiving IV therapy?

In the context of patients receiving IV therapy, a significant risk associated with the procedure is the potential for infection at the insertion site. This risk arises because the insertion of an intravenous line breaks the skin barrier, which can introduce bacteria and lead to localized infections or even systemic infections, such as bacteremia or sepsis.

Proper aseptic technique during insertion and care of the IV site is essential in minimizing this risk. Regular monitoring of the insertion site for signs of infection—such as redness, swelling, warmth, or discharge—is also critical for early detection and management.

While reduced mobility, enhanced fluid absorption, and lowered heart rate could be concerns in certain situations, they do not present the same acute and significant risk that infection at the insertion site does during IV therapy. Infection control is a paramount consideration in the administration of IV therapy, making this risk particularly noteworthy.